Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Impact of Neoadjuvant Endocrine Therapy on Surgical Outcomes in Patients With Stage 2 to 3 Invasive Lobular Carcinoma: A Prospective Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07483307
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:11.112400+00:00
Published At
2026-03-19T00:00:00+00:00
Record Updated At
2026-03-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Breast Cancer", "HER2-negative Breast Cancer", "HER2 Negative Breast Carcinoma", "ER+ Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-19"
protocolSection.identificationModule.nctId
"NCT07483307"
protocolSection.identificationModule.officialTitle
"Impact of Neoadjuvant Endocrine Therapy on Surgical Outcomes in Patients With Stage 2 to 3 Invasive Lobular Carcinoma: A Prospective Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • HER2-negative Breast Cancer (protocolSection.conditionsModule.conditions)
  • HER2 Negative Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • ER+ Breast Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.